FindTrial
Sign In

ADD ON EFFECT OF BHUDHATRAYADIYOG WITH ORAL DIABETIC DRUGS IN MANAGEMENT OF PRAMEHA

A RANDOMIZED OPEN CONTROLLED CLINICAL STUDY OF ADD ON EFFECT OF BHUDHATRAYADIYOG WITH ONGOING ORAL HYPOGLYCEMIC AGENT IN THE MANAGEMENT OF PRAMEHA W.S.R TO DM-2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039500
Enrollment
80
Registered
2022-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Sponsors

Yashwant ayurvedic collage
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having BSL >126mg/dl PP >200 Patients of age group 30-75years Patients having type 2 DM Patients on oral hypoglycemic drugs

Exclusion criteria

Exclusion criteria: Type 1 DM ACUTE COMPLICATIONS - Diabetic ketoacidosis hyper osmolar rate, diabetic nephropathy, Diabetic gangrene, autonomic neuropathy Pregnant and lactating mother

Design outcomes

Primary

MeasureTime frame
Good improvement, Moderately improvement, mild improvement and Unchanged in signs and symptomsTimepoint: At baseline ,15 days ,30 days and 1 month—

Secondary

MeasureTime frame
Improved retinopathy, nephropathyTimepoint: At baseline ,15th day ,30th day ,60th day—

Countries

India

Contacts

Public ContactVIVEK SUDARSHAN KHATANE
Vasudha.borakhade@gmail.com9822885710

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026